ZA919662B - Pharmaceutical preparations containing functionalized vinyl azoles,use of these vinyl azoles for the production of pharmaceutical agents,vinyl azoles themselves as well as process for their production - Google Patents

Pharmaceutical preparations containing functionalized vinyl azoles,use of these vinyl azoles for the production of pharmaceutical agents,vinyl azoles themselves as well as process for their production

Info

Publication number
ZA919662B
ZA919662B ZA919662A ZA919662A ZA919662B ZA 919662 B ZA919662 B ZA 919662B ZA 919662 A ZA919662 A ZA 919662A ZA 919662 A ZA919662 A ZA 919662A ZA 919662 B ZA919662 B ZA 919662B
Authority
ZA
South Africa
Prior art keywords
production
vinyl azoles
azoles
vinyl
themselves
Prior art date
Application number
ZA919662A
Other languages
English (en)
Inventor
Peter Strehlke
Strehlke Peter
Rolf Bohlmann
Bohlmann Rolf
Martin Schneider
Schneider Martin
Yukishige Nishino
Nishino Yukishige
Hans-Peter Muhn-Seipoldy
Muhn-Seipoldy Hans-Peter
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA919662B publication Critical patent/ZA919662B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA919662A 1990-12-07 1991-12-06 Pharmaceutical preparations containing functionalized vinyl azoles,use of these vinyl azoles for the production of pharmaceutical agents,vinyl azoles themselves as well as process for their production ZA919662B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4039559A DE4039559A1 (de) 1990-12-07 1990-12-07 Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln

Publications (1)

Publication Number Publication Date
ZA919662B true ZA919662B (en) 1992-09-30

Family

ID=6420083

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919662A ZA919662B (en) 1990-12-07 1991-12-06 Pharmaceutical preparations containing functionalized vinyl azoles,use of these vinyl azoles for the production of pharmaceutical agents,vinyl azoles themselves as well as process for their production

Country Status (17)

Country Link
US (1) US5344834A (he)
EP (1) EP0550697A1 (he)
JP (1) JPH06503818A (he)
KR (1) KR930703263A (he)
CN (1) CN1064863A (he)
AU (1) AU660296B2 (he)
CA (1) CA2097824C (he)
CS (1) CS369691A3 (he)
DE (1) DE4039559A1 (he)
FI (1) FI932572A (he)
HU (1) HUT64036A (he)
IE (1) IE914259A1 (he)
IL (1) IL100274A (he)
NO (1) NO304428B1 (he)
PT (1) PT99714B (he)
WO (1) WO1992010482A1 (he)
ZA (1) ZA919662B (he)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
EP0943333A1 (de) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
US20020086856A1 (en) 1998-03-18 2002-07-04 Alfred Schmidt Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
CN100358866C (zh) * 2004-04-08 2008-01-02 上海交通大学 含对强碱不稳定取代基的n-乙烯基取代吡咯的制备方法
JP6470984B2 (ja) * 2015-01-27 2019-02-13 学校法人東日本学園 アロマターゼ阻害剤及びこれを含む医薬
CN105732977B (zh) * 2016-01-30 2018-03-02 宝鸡文理学院 一种可溶性聚苯并二噻唑‑酰胺荧光聚合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580535A (en) * 1976-08-27 1980-12-03 Ici Ltd Substituted ketones and their use as herbicides
EP0003884A3 (en) * 1978-02-23 1979-09-19 Imperial Chemical Industries Plc Alpha-beta unsaturated ketone derivatives useful as herbicides
DE2826760A1 (de) * 1978-06-19 1980-01-03 Hoechst Ag Derivate des 1,2,4-triazols
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
GB8716650D0 (en) * 1987-07-15 1987-08-19 Ici Plc Use of olefinic compounds

Also Published As

Publication number Publication date
DE4039559A1 (de) 1992-06-11
WO1992010482A1 (de) 1992-06-25
PT99714B (pt) 1999-05-31
IL100274A0 (en) 1992-09-06
AU660296B2 (en) 1995-06-22
PT99714A (pt) 1992-10-30
CN1064863A (zh) 1992-09-30
IE914259A1 (en) 1992-06-17
HUT64036A (en) 1993-11-29
JPH06503818A (ja) 1994-04-28
NO932044L (no) 1993-06-04
CA2097824A1 (en) 1992-06-08
EP0550697A1 (de) 1993-07-14
FI932572A0 (fi) 1993-06-04
NO304428B1 (no) 1998-12-14
NO932044D0 (no) 1993-06-04
HU9301657D0 (en) 1993-09-28
KR930703263A (ko) 1993-11-29
US5344834A (en) 1994-09-06
IL100274A (he) 1996-08-04
FI932572A (fi) 1993-06-04
AU9045491A (en) 1992-07-08
CA2097824C (en) 2003-04-08
CS369691A3 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
HU911815D0 (en) Process for the production of medical preparations containing pravastatine for the prevention of, relapse after vasodilator operation
HU912452D0 (en) Process for the production of medical preparations containing organic compounds
AU7820191A (en) New imidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
AU1274888A (en) Process for preparing 1,1,1-trifluoro-2,2-dichloroethane by hydrofluorination in the presence of catalysts
HU9201937D0 (en) Aryl ethers, process for their production, and for the production of medical preparations containing them as active agents
HU910929D0 (en) Process for the production of 2,8-dioxa-bicyclo/3,2,1/octane derivatives and medical preparations containing them
EP0445589A3 (en) Process for the preparation of 1,4-alkylenediamines
HU911750D0 (en) Process for the production of medical preparations containing substituted betha-hydroxy-ethylamines
ZA919662B (en) Pharmaceutical preparations containing functionalized vinyl azoles,use of these vinyl azoles for the production of pharmaceutical agents,vinyl azoles themselves as well as process for their production
HU905358D0 (en) Substituted bicycloheptane-dion-derivatives, process for the production of the compounds, and herbicide preparations containing the derivatives
HU913267D0 (en) Process for the production of 1-(3,4-dihydro-2-oxo-1h-kinoline-6-yl)-2-(4-)2-phenyl-ethyl-(piperidine-1-yl)-ethanole and ethanone, and of medical preparations containing them as active agents
HU9200354D0 (en) Process for the production of 2-ethyl-4-/2'/-1h-1,2,3,4-tetrazole-5-yl/-biphenyl-4-yl/-metoxi/-kinoline-hydrocloride
ZA905932B (en) 14,17alpha-etheno-and-ethanoestratrienes,processes for the preparation of these compounds,as well as their use for the production of medicinal agents
ZA916433B (en) Novel pyrrolobenzimidazoles,imidazobenzoxazinones and imidazoquinolones,process for their preparation and their use and preparations containing the compounds
EP0292808A3 (en) Substituted vinyl cephalosporins, process for their preparation and their use as medicines
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
EP0297296A3 (en) Process for the preparation of 2,2'-oxybisûn,n-dimethyl-ethylamine¨
AU624746B2 (en) Process for the preparation of 5-amino-3-chlorosulfonyl-1,2,4-triazole
ZA949347B (en) 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceutical agents containing these compounds and process for their production.
ZA914376B (en) Benzimidazole derivatives,their preparation process,the intermediates obtained,their use as medicaments and the pharmaceutical compositions containing them
GB2272218B (en) Process for the preparation of 2,4,6-triiodo-isophthalic acid bis-(1,3-dihydroxypropylamide) derivatives
EP0475272A3 (en) Process for the preparation of 2,3,5-trimethyl-p-benzoquinone
AU2886595A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents
HU913228D0 (en) Process for the production of 5-aroil-2,3-dihydro-1h-pyrrholyzine-1,1-dicarboxylates